Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Parmax Pharma Limited has informed the stock exchanges that the trading window for its securities will remain closed for designated persons starting April 1, 2026, until 48 hours after the declaration of financial results for the quarter and financial year ending March 31, 2026. This is a standard compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015, aimed at preventing insiders from trading while in possession of unpublished price-sensitive information. The Board meeting date to consider the Q4 and FY26 results will be communicated separately.
Designated persons (including directors, key managerial personnel, and their immediate relatives) cannot buy or sell Parmax Pharma shares during this closed window. For retail investors, this is routine and signals that the company is preparing to announce its annual results soon.